grant

Novel soluble guanylate cyclase activators for pulmonary artery hypertension [ 2010 - 2011 ]

Also known as: Drug development for pulmonary hypertension

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/1000657]

Researchers: Prof David Kaye (Principal investigator) ,  Dr Guy Krippner

Brief description Pulmonary hypertension (elevated blood pressure in the lungs) is a life-threatening condition with few treatment options. We have recently identified a new class of drug that may improve blood vessel function in the lungs and thereby provide a new drug for the management of this group of patients.

Funding Amount $AUD 474,087.90

Funding Scheme NHMRC Development Grants

Notes Development Grant

Click to explore relationships graph
Identifiers
Viewed: [[ro.stat.viewed]]